Zebra Technologies Corporation

(NASDAQ Global Select)
Back to all articles
Bullish +75

Zebra Technologies stock gains after Needham raises price target on strong Q2 2026 results

AI-generated analysis

📈 Needham reiterated a Buy rating on Zebra Technologies and raised its price target to USD 435 following record Q2 2026 earnings.

💰 Zebra reported net sales growth of 20.4% year-over-year in Q2 2026, driven by strong demand for AI-enabled automation solutions.

🚀 The company launched the KC401 self-service kiosk to free up retail associate capacity for higher-value tasks like merchandising.

🏥 Zebra deepened its healthcare footprint with a rollout at University Health, embedding devices into critical inpatient workflows.

📊 Shares of ZBRA closed up 1.94% at USD 347.81 on September 17, 2026, reflecting positive market reaction to the analyst upgrade.

🔮 Needham's higher price target implies roughly 24% upside from recent trading levels based on sustained operational momentum.

📈 Long-term projections suggest revenue could reach USD 7.2 billion by 2029 with annual growth rates around 7%.

Bullish Signals
  • Needham reiterated a Buy rating and raised the price target to USD 435, implying roughly 24% upside from recent trading levels.
  • The company delivered record Q2 2026 results with net sales growth of 20.4% year-over-year and record margins.
  • Zebra raised its full-year outlook, underscoring strong operational momentum in both hardware and software businesses.
  • The launch of the KC401 kiosk is designed to free the equivalent capacity of four store associates per location for higher-value tasks.
  • A recent deployment with University Health demonstrates Zebra's ability to integrate devices into mission-critical hospital workflows.
Full Analysis
Zebra Technologies (ZBRA) shares climbed on September 17, 2026, following a rating upgrade from Needham & Co., which reiterated its Buy rating and raised the price target to USD 435. The analyst firm cited record Q2 2026 results as the primary driver, noting net sales growth of 20.4% year-over-year alongside improved margins and a raised full-year outlook. This positive sentiment reflects strong investor confidence in Zebra's operational momentum within its core hardware and software businesses. Beyond the earnings beat, Zebra is advancing its automation narrative with the launch of the KC401 self-service kiosk and deepening healthcare integrations. The new 10-inch IP65-sealed device is designed to handle routine inquiries in retail and hospitality, effectively freeing up store associates for higher-value tasks like merchandising. Simultaneously, a recent rollout with University Health demonstrates Zebra's ability to embed mobile computers into critical hospital workflows where device downtime directly impacts patient care. Market data indicates sustained bullishness as ZBRA shares traded around USD 345.70 intraday on September 17, up approximately 1.32%, before closing at USD 347.81 with a gain of 1.94%. The raised price target implies roughly 24% upside from recent trading levels, suggesting the market views Zebra's AI-driven portfolio and M&A execution as capable of sustaining long-term growth. Analysts project revenue reaching approximately USD 7.2 billion by 2029, assuming annual growth rates near 7%.